Cargando…

Mesenchymal Stromal Cells Attenuate Infection-Induced Acute Respiratory Distress Syndrome in Animal Experiments: A Meta-Analysis

Mesenchymal stromal cell (MSC) therapy is a potential therapy for treating acute lung injury (ALI) or acute respiratory distress syndrome (ARDS), which was widely studied in the last decade. The purpose of our meta-analysis was to investigate the efficacy of MSCs for simulated infection-induced ALI/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fengyun, Wang, LiXin, Zhou, Xinhua, Qiang, Bin, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784610/ https://www.ncbi.nlm.nih.gov/pubmed/33164559 http://dx.doi.org/10.1177/0963689720969186

Ejemplares similares

The efficacy of mesenchymal stromal cell-derived therapies for acute respiratory distress syndrome—a meta-analysis of preclinical trials
por: Wang, Fengyun, et al.
Publicado: (2020)

Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome
por: Liu, Chang, et al.
Publicado: (2022)

Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome
por: Horie, Shahd, et al.
Publicado: (2016)

Mesenchymal stromal cell application as an emerging translational medicine for acute respiratory distress syndrome
por: Lee, Hyun Jung, et al.
Publicado: (2020)

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome
por: Simonson, Oscar E., et al.
Publicado: (2016)

Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome
por: Tovar, Isabel, et al.
Publicado: (2020)

Mesenchymal stromal cell therapy for acute respiratory distress syndrome due to coronavirus disease 2019
por: Whittaker Brown, Stacey-Ann, et al.
Publicado: (2022)

Understanding the Role of Mesenchymal Stromal Cells in Treating COVID-19 Acute Respiratory Distress Syndrome
por: O’Kane, Cecilia M., et al.
Publicado: (2022)

Enhancing the Efficacy of Mesenchymal Stromal Cells in COVID-19–related Acute Respiratory Distress Syndrome
por: Zhang, Haibo, et al.
Publicado: (2023)

Mesenchymal Stem/Stromal Cells: SAFETY OF CORD TISSUE DERIVED MESENCHYMAL STROMAL CELLS IN COVID-19 RELATED ACUTE RESPIRATORY DISTRESS SYNDROME
por: Shaz, B., et al.
Publicado: (2022)

Concise Review: Mesenchymal Stromal Cell‐Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes
por: Johnson, Christian L., et al.
Publicado: (2017)

Mesenchymal stromal cells alleviate acute respiratory distress syndrome through the cholinergic anti-inflammatory pathway
por: Zhang, Xiaoran, et al.
Publicado: (2022)

Five-Year Follow-up after Mesenchymal Stromal Cell–based Treatment of Severe Acute Respiratory Distress Syndrome
por: Simonson, Oscar E., et al.
Publicado: (2020)

Protease Activated Receptors: A Pathway to Boosting Mesenchymal Stromal Cell Therapeutic Efficacy in Acute Respiratory Distress Syndrome?
por: Gupta, Naveen
Publicado: (2022)

A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19
por: Bowdish, Michael E., et al.
Publicado: (2022)

Safety and efficacy of clinical-grade, cryopreserved menstrual blood mesenchymal stromal cells in experimental acute respiratory distress syndrome
por: Alcayaga-Miranda, Francisca, et al.
Publicado: (2023)

Feasibility Study of Cord Tissue Derived Mesenchymal Stromal Cells in COVID-19-Related Acute Respiratory Distress Syndrome
por: Shaz, Beth H, et al.
Publicado: (2023)

Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome
por: Ringdén, Olle, et al.
Publicado: (2022)

Effects of mesenchymal stromal cell-derived extracellular vesicles in acute respiratory distress syndrome (ARDS): Current understanding and future perspectives
por: Su, Yue, et al.
Publicado: (2021)

Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review
por: Sadeghi, Behnam, et al.
Publicado: (2022)

The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials
por: Wang, Fengyun, et al.
Publicado: (2023)

The fluid management and hemodynamic characteristics of PiCCO employed on young children with severe hand, foot, and mouth disease—a retrospective study
por: Wang, Fengyun, et al.
Publicado: (2021)

Intrapulmonary autologous transplant of bone marrow-derived mesenchymal stromal cells improves lipopolysaccharide-induced acute respiratory distress syndrome in rabbit
por: Mokhber Dezfouli, Mohammad Reza, et al.
Publicado: (2018)

Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection
por: Mallis, Panagiotis, et al.
Publicado: (2020)

Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology
por: Silva, Johnatas D., et al.
Publicado: (2019)

Recombinant Antithrombin Attenuates Acute Respiratory Distress Syndrome in Experimental Endotoxemia
por: Okamoto, Haruka, et al.
Publicado: (2021)

Mechanical ventilation with heliox in an animal model of acute respiratory distress syndrome
por: Beurskens, Charlotte J, et al.
Publicado: (2014)

Biphasic positive airway pressure spontaneous breathing attenuates lung injury in an animal model of severe acute respiratory distress syndrome
por: Zhou, Leilei, et al.
Publicado: (2022)

Mesenchymal stem cells with downregulated Hippo signaling attenuate lung injury in mice with lipopolysaccharide-induced acute respiratory distress syndrome
por: Li, Lang, et al.
Publicado: (2019)

Alveolar recruitment maneuver attenuates extravascular lung water in acute respiratory distress syndrome
por: Chung, Fu-Tsai, et al.
Publicado: (2017)

Abstract 12 Phase I Study of Cord Tissue Derived Mesenchymal Stromal Cells in COVID-19–Related Acute Respiratory Distress Syndrome
por: Kraft, Bryan, et al.
Publicado: (2022)

Mesenchymal stem cells - a promising therapy for Acute Respiratory Distress Syndrome
por: Hayes, Mairead, et al.
Publicado: (2012)

Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome
por: Han, Jibin, et al.
Publicado: (2019)

“Obesity Paradox” in Acute Respiratory Distress Syndrome: Asystematic Review and Meta-Analysis
por: Zhi, Guo, et al.
Publicado: (2016)

MicroRNA-574-5p Attenuates Acute Respiratory Distress Syndrome by Targeting HMGB1
por: He, Binchan, et al.
Publicado: (2021)

Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases
por: Rolandsson Enes, Sara, et al.
Publicado: (2021)

Community Experience With Acute Respiratory Distress Syndrome in the Prone Position
por: Khan, Fahmida, et al.
Publicado: (2019)

Bench-to-bedside: The use of local anesthetics to attenuate inflammation in acute respiratory distress syndrome
por: Krishnamoorthy, Vijay, et al.
Publicado: (2014)

Desflurane Attenuates Ventilator-Induced Lung Injury in Rats with Acute Respiratory Distress Syndrome
por: Lin, Xue, et al.
Publicado: (2018)

Activated protein C attenuates pulmonary coagulopathy in patients with acute respiratory distress syndrome
por: Cornet, A.D., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mdhu1eqjakr08mclf16es4b0b5